Shenzhen Weiguang Biological Products Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Weiguang Biological Products has a total shareholder equity of CN¥2.0B and total debt of CN¥451.9M, which brings its debt-to-equity ratio to 22.9%. Its total assets and total liabilities are CN¥2.7B and CN¥691.9M respectively. Shenzhen Weiguang Biological Products's EBIT is CN¥208.2M making its interest coverage ratio 238.8. It has cash and short-term investments of CN¥192.3M.
Key information
22.9%
Debt to equity ratio
CN¥451.87m
Debt
Interest coverage ratio | 238.8x |
Cash | CN¥192.33m |
Equity | CN¥1.97b |
Total liabilities | CN¥691.95m |
Total assets | CN¥2.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002880's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥168.0M).
Long Term Liabilities: 002880's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥524.0M).
Debt to Equity History and Analysis
Debt Level: 002880's net debt to equity ratio (13.2%) is considered satisfactory.
Reducing Debt: 002880's debt to equity ratio has increased from 3.9% to 22.9% over the past 5 years.
Debt Coverage: 002880's debt is well covered by operating cash flow (61.6%).
Interest Coverage: 002880's interest payments on its debt are well covered by EBIT (238.8x coverage).